Heparin-induced thrombocytopenia natural history, complications and prognosis: Difference between revisions
mNo edit summary |
mNo edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Heparin-induced thrombocytopenia}} | {{Heparin-induced thrombocytopenia}} | ||
{{CMG}}; | {{CMG}}; | ||
==Overview== | ==Overview== |
Revision as of 19:43, 17 June 2016
Heparin-induced thrombocytopenia |
Differentiating Heparin-induced thrombocytopenia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Heparin-induced thrombocytopenia natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Heparin-induced thrombocytopenia natural history, complications and prognosis |
FDA on Heparin-induced thrombocytopenia natural history, complications and prognosis |
CDC on Heparin-induced thrombocytopenia natural history, complications and prognosis |
Heparin-induced thrombocytopenia natural history, complications and prognosis in the news |
Blogs on Heparin-induced thrombocytopenia natural history, complications and prognosis |
Directions to Hospitals Treating Heparin-induced thrombocytopenia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];